Navigation Links
MeridianRx Announces New Client
Date:12/29/2010

DETROIT, Dec. 29, 2010 /PRNewswire/ -- MeridianRx is pleased to welcome Health Plan of Michigan as its newest client.

Effective January 1, 2011, MeridianRx will handle processing and payment of prescription drug claims for the Health Plan of Michigan (HPM). HPM is the state's largest managed Medicaid plan, serving over 280,000 Michigan residents.

MeridianRx, a Pharmacy Benefit Manager (PBM) program, creates savings for clients by using pharmacy networks, negotiating with drug manufacturers and developing drug formularies. MeridianRx also helps clients improve quality by providing access to a live MeridianRx pharmacist, who can respond immediately to questions or concerns.  

"Our relationship with MeridianRx will significantly improve our cost-effectiveness as well as the quality of care for our members," said Rene Acker, R.Ph., HPM's Director of Pharmacy. "Their innovative use of technology in online claims adjudication and messaging will not only control costs, but their commitment to clinical support gives our members better quality pharmacy services."


'/>"/>
SOURCE MeridianRx
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Globus Medical Announces 2,000th Patient Treated with TRANSITION® Stabilization System
2. Omeros Announces Positive Clinical Results of OMS201 in Patients Undergoing Ureteroscopy
3. Savient Pharmaceuticals Announces Search for CEO
4. Caraco Pharmaceutical Laboratories, Ltd. Announces Extension and Future Termination of Distribution Agreements with Sun Pharma
5. K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission
6. Mindray Medical Announces Shareholder Resolutions Adopted at 2010 Annual General Meeting
7. Vicus Therapeutics Announces Initiation of Phase 2 Trial to Evaluate VT-122 in Patients with Liver Cancer Receiving Nexavar
8. Cepheid Announces European Release of Xpert Flu, Delivering Simultaneous Detection and Differentiation of Flu A, Flu B, and 2009 H1N1 Strain
9. Generex Announces Extension of Global Medical Direct Acquisition Closing Date
10. Zimmer Announces Acquisition of SoPlus Orthopaedic Surgical Power Tools Company
11. SCOLR Pharma, Inc. Announces Intention to Voluntarily Delist From NYSE AMEX Exchange
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment is ... period The Cardiology Devices segment is likely to ... 15 Mn in 2018 over 2017. By the end of ... valuation close to US$ 700 Mn, expanding at a CAGR ... dominated the Asia Pacific reprocessed medical ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... April 26, 2017 , ... Datos Health , developer of ... Med-e-Mass , the largest Electronic Medical Records (EMR) provider in South Africa. ... incentives to a patient’s remote health progress, empowering the patient to take direct responsibility ...
(Date:4/26/2017)... ... ... Infertility may be a result of an underlying pelvic ... become pregnant upon treating their diagnosis. , To properly diagnose patients, ... can provide the necessary information to diagnose and treat your problem. , ...
(Date:4/26/2017)... ... April 26, 2017 , ... Want to learn ... ( CRISPRCas.pioneer.com ) that demonstrates how this advanced plant breeding technology is a ... food, with fewer resources. It highlights the business’ principles, research and collaboration efforts ...
(Date:4/26/2017)... ... April 26, 2017 , ... MYOLYN, a ... announce that it has received 510(k) clearance from the U.S. Food & Drug ... MyoCycle Pro. , Both devices are stationary cycling systems that use MYOLYN’s patent-pending ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... they have signed an agreement to be the preferred physical therapy provider for ... and returning them to Derby City CrossFit as quickly and effectively as possible, ...
Breaking Medicine News(10 mins):